These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 12168829

  • 1. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors.
    Cohen LA, Marks PA, Rifkind RA, Amin S, Desai D, Pittman B, Richon VM.
    Anticancer Res; 2002; 22(3):1497-504. PubMed ID: 12168829
    [Abstract] [Full Text] [Related]

  • 2. Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA).
    Cohen LA, Amin S, Marks PA, Rifkind RA, Desai D, Richon VM.
    Anticancer Res; 1999; 19(6B):4999-5005. PubMed ID: 10697502
    [Abstract] [Full Text] [Related]

  • 3. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.
    Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, Thaler HT, Rifkind RA, Marks PA, Richon VM.
    Cancer Res; 2000 Sep 15; 60(18):5165-70. PubMed ID: 11016644
    [Abstract] [Full Text] [Related]

  • 4. LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model.
    Cohen LA, Pittman B, Wang CX, Aliaga C, Yu L, Moyer JD.
    Cancer Res; 2001 Dec 15; 61(24):8683-8. PubMed ID: 11751385
    [Abstract] [Full Text] [Related]

  • 5. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells.
    Munster PN, Troso-Sandoval T, Rosen N, Rifkind R, Marks PA, Richon VM.
    Cancer Res; 2001 Dec 01; 61(23):8492-7. PubMed ID: 11731433
    [Abstract] [Full Text] [Related]

  • 6. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
    Yin D, Ong JM, Hu J, Desmond JC, Kawamata N, Konda BM, Black KL, Koeffler HP.
    Clin Cancer Res; 2007 Feb 01; 13(3):1045-52. PubMed ID: 17289901
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid.
    Rikiishi H, Shinohara F, Sato T, Sato Y, Suzuki M, Echigo S.
    Int J Oncol; 2007 May 01; 30(5):1181-8. PubMed ID: 17390020
    [Abstract] [Full Text] [Related]

  • 10. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Fedier A, Dedes KJ, Imesch P, Von Bueren AO, Fink D.
    Int J Oncol; 2007 Sep 01; 31(3):633-41. PubMed ID: 17671692
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid.
    Marchion DC, Bicaku E, Daud AI, Richon V, Sullivan DM, Munster PN.
    J Cell Biochem; 2004 May 15; 92(2):223-37. PubMed ID: 15108350
    [Abstract] [Full Text] [Related]

  • 16. Effect of dietary lycopene on N-methylnitrosourea-induced mammary tumorigenesis.
    Cohen LA, Zhao Z, Pittman B, Khachik F.
    Nutr Cancer; 1999 May 15; 34(2):153-9. PubMed ID: 10578482
    [Abstract] [Full Text] [Related]

  • 17. Induction of adipocyte-specific gene expression is correlated with mammary tumor regression by the retinoid X receptor-ligand LGD1069 (targretin).
    Agarwal VR, Bischoff ED, Hermann T, Lamph WW.
    Cancer Res; 2000 Nov 01; 60(21):6033-8. PubMed ID: 11085524
    [Abstract] [Full Text] [Related]

  • 18. Low zinc intake suppressed N-methyl-N-nitrosourea-induced mammary tumorigenesis in Sprague-Dawley rats.
    Lee S, Simpson M, Nimmo M, Xu Z.
    Carcinogenesis; 2004 Oct 01; 25(10):1879-85. PubMed ID: 15205360
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.